Αναζητήστε φάρμακα πιο γρήγορα. Δοκιμάστε τον ελεγκτή αλληλεπιδράσεων.
Αναζητήστε φάρμακα πιο γρήγορα. Δοκιμάστε τον ελεγκτή αλληλεπιδράσεων.
Σύνδεση
Εγγραφή
ABCD² score for TIA

ABCD² score for TIA

Estimation of stroke risk after a transient ischemic attack

Επιπλέον πληροφορίες

Εκτύπωση ή αποθήκευση ως PDF
Οδηγίες και παραπομπές

Προειδοποίηση

Αυτό το εργαλείο προορίζεται μόνο για εκπαιδευτικούς σκοπούς, δεν αντιπροσωπεύει και δεν αντικαθιστά επαγγελματικές συμβουλές. Αυτό το εργαλείο δεν πρέπει να χρησιμοποιείται για την παροχή ιατρικών διαγνώσεων ή/και ιατρικών θεραπειών.
General description
A transient ischemic attack (TIA) is a temporary period of symptoms similar to a stroke, resulting from a temporary disruption in blood flow to the central nervous system, that doesn't cause permanent damage. However, there is an increased risk of stroke following TIA – in about a quarter of stroke patients, a TIA has preceded a stroke.
The ABCD² score is a seven-point risk-stratification tool developed to identify patients at high risk of stroke following a TIA. It is based on the combination of 5 variables: Age, Blood pressure, Clinical features, Duration and Diabetes - ABCD². The resulting scores stratify the patients into low (0–3 points), moderate (4–5 points) and high (6–7 points) risk categories. For each of the categories a 2-, 7- and 90-day stroke risk estimation is given.
The ABCD² score was created by Johnston et al. by merging two previously validated clinical decision rules – the ABCD and the California scores. It has been externally validated and is endorsed by the European Stroke Organisation (ESO) and American Heart Association (AHA) guidelines as one of the TIA risk stratification scores.
The ESO guidelines on management of TIA use ABCD² score of ≥ 4 to define high risk TIA. They also recommend against using prediction tools (like ABCD² score) alone to identify high risk patients or to make triage and treatment decisions in suspected TIA patients due to limited sensitivity.

Result ranges

Low risk
0–3
Moderate risk
4–5
High risk
6–7

Formula

Age: < 60 years (0 points), ≥ 60 years (+1 point)
Blood pressure: < 140/90 mmHg (0 points), ≥ 140/90 mmHg (+1 point)
Clinical symptoms of TIA: unilateral weakness (+2 points), speech disturbance without weakness (+1 point), other symptoms (0 points)
Duration of symptoms: ≥ 60 minutes (+2 points), 10–59 minutes (+1 point), < 10 minutes (0 points)
History of diabetes (+1 point)

References

Johnston S, Rothwell P, Nguyen-Huynh M, Giles M, Elkins J, Bernstein A et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. The Lancet. 2007;369(9558):283-292.
Fothergill A, Christianson T, Brown R, Rabinstein A. Validation and Refinement of the ABCD2 Score. Stroke. 2009;40(8):2669-2673.

Έκδοση

1

Σχετικά με αυτό το εργαλείο

A transient ischemic attack (TIA) is a temporary period of symptoms similar to a stroke, resulting from a temporary disruption in blood flow to the central nervous system, that doesn't cause permanent damage. However, there is an increased risk of stroke following TIA – in about a quarter of stroke patients, a TIA has preceded a stroke.
The ABCD² score is a seven-point risk-stratification tool developed to identify patients at high risk of stroke following a TIA. It is based on the combination of 5 variables: Age, Blood pressure, Clinical features, Duration and Diabetes - ABCD². The resulting scores stratify the patients into low (0–3 points), moderate (4–5 points) and high (6–7 points) risk categories. For each of the categories a 2-, 7- and 90-day stroke risk estimation is given.
The ABCD² score was created by Johnston et al. by merging two previously validated clinical decision rules – the ABCD and the California scores. It has been externally validated and is endorsed by the European Stroke Organisation (ESO) and American Heart Association (AHA) guidelines as one of the TIA risk stratification scores.
The ESO guidelines on management of TIA use ABCD² score of ≥ 4 to define high risk TIA. They also recommend against using prediction tools (like ABCD² score) alone to identify high risk patients or to make triage and treatment decisions in suspected TIA patients due to limited sensitivity.
Drugs app phone

Χρησιμοποιήστε την εφαρμογή Mediately

Λήψη στοιχείων φαρμάκων πιο γρήγορα.

Σαρώστε με την κάμερα του τηλεφώνου σας.
4.9

Πάνω 36k αξιολογήσεις

Χρησιμοποιήστε την εφαρμογή Mediately

Λήψη στοιχείων φαρμάκων πιο γρήγορα.

4.9

Πάνω 36k αξιολογήσεις

Λήψη

Πηγαίνετε πέρα από τις πληροφορίες φαρμάκων με το PRO

Επιλύστε τις αλληλεπιδράσεις, δείτε τους περιορισμούς χρήσης και βρείτε όλες τις άλλες απαντήσεις με τον βοηθό ΤΝ σας, την Elly.

Preveri, kaj ponuja PRO
Χρησιμοποιούμε cookies Τα cookies μας βοηθούν στο να παρέχουμε τη βέλτιστη εμπειρία χρήσης της τοποθεσίας web μας. Χρησιμοποιώντας την τοποθεσία web μας, συμφωνείτε ως προς τη χρήση των cookies. Μάθετε περισσότερα σχετικά με το πώς χρησιμοποιούμε τα cookies στην Πολιτική cookies μας.